1800results about How to "Slow change" patented technology

Medical devices, and in particular implantable medical devices, including self-expanding stents, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment.

A display pixel unit provides reduced capacitative coupling between a pixel electrode and a source line. The unit includes a transistor, the pixel electrode, and the source line. The source line includes an extension that provides a source for the transistor. A patterned conductive portion is disposed adjacent to the source line.

Disclosed is an exposure apparatus which includes a projection optical system for projecting a pattern of a reticle onto a substrate, wherein the substrate is exposed through a liquid medium kept at least in a portion between the substrate and an optical element of the projection optical system which optical element is nearest to the substrate, a supplying system for supplying a liquid medium, a collecting system for collecting a liquid medium, and an exhausting system for removing a bubble in the liquid medium through a bubble removing material having such property that it passes a gas but it does not pass a liquid.

A method for forming a modified low-k SiOCH film on a substrate, includes: providing a low-k SiOCH film formed on a substrate by flowable CVD; exposing the low-k SiOCH film to a gas containing a Si—N bond in its molecule without applying electromagnetic energy to increase Si—O bonds and/or Si—C bonds in the film; and then curing the low-k SiOCH film.

Systems and methods are described for interactively and graphically interfacing with a user on an HVAC system controlled by a thermostat. The user interface is implemented on a touch screen display on a remote wirelessly connected device such as smartphone or a tablet PC. The interface displays a screen that mimics the display on the thermostat including allowing one or more input methods that are analogous to input methods used on the thermostat. Touch screen gestures such as touch and drag, touch and hold and tapping are used in an intuitive way. The user experience is enhanced by allowing large-scale changes while reducing the risk of sudden unintended changes. The control signals are judiciously tailored to protect the HVAC equipment from unwarranted over-controlling, reduce unnecessary network traffic, and prevent the waste of energy.

A system and process for controlling the coding bit rate of streaming media data is presented where a server streams data that exhibits one of a number of coding bit rates supported by the server. Initially, the server chooses the coding bit rate. However, after this startup period, the client provides coding bit rate requests. The server transmits the streaming media data at the most appropriate supported coding bit rate closest to the rate requested. The coding bit rates requested are those estimated to provide a high quality playback of the streaming data while still keeping a decoder buffer of the client filled to a desired level. A leaky bucket model is incorporated so that the changes in buffer duration due to natural variation in the instantaneous coding bit rate are not mistaken for changes in buffer duration due to network congestion.

A server at the edge of a broadband network distributes multimedia content streams to clients, while ensuring that the first data delivered to each client is key data (milestones) needed for correctly decoding the stream content. This is obtained by buffering the packets in the incoming stream and transmitting the packets from the buffer in an outgoing stream, starting with the most recent milestone placed in the buffer before a request to join the respective incoming stream is received. As the writing to and reading from the buffer are performed at different rates, the incoming and outgoing streams are eventually synchronized, at which point the client may be switched to receive the incoming stream directly.

One or more nodes on a communication network are selected and set as one node group. In each of the nodes, group identification information representing the node group to which the node belongs is stored in advance. The group identification information is attached to the header of a data packet to be transmitted, so that nodes constituting a node group that should commonly receive data can be readily identified by comparing the group identification information imparted to the transmitted data packet and the group identification information stored in each receiving node. Given node can choose to become a node of a particular function, such as a clock master node, in which case control is performed to delete, from the node group, a node having so far played the role of the node of the particular function in such a manner that there exists only one node of the particular function per node group.

An operation flow of each node is dynamically changed according to a user request or a situation. A client (205) includes: a step (415) of extracting a script for a lower node from scripts in which processing is preset for a plurality of nodes to distribute the script extracted to the lower node; a step of executing processing for a self node from the script; a step of causing the lower node to receive the script distributed to execute processing for the node; and a step 410 of causing the lower node to extract a script for a node lower than the self node from the scripts, and to distribute the extracted script to the lower node if the script for the lower node is present. Based on a script executed by each node, an event from a lowest sensor node is sent through an intermediate node to the client 205.

The invention relates to a buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using an electric current and to a method for introducing biologically active molecules into animal or human cells using an electric current and a buffer solution. The inventive buffer solution has a buffering capacity of at least 20 mmol*I⁻¹*pH⁻¹ and an ionic strength of at least 200 mmol*I⁻¹ during a change to the pH value from pH 7 to pH 8 and at a temperature of 25° C. The use of a buffer solution of this type in the corresponding method allows biologically active molecules to be introduced into animal and human cells with a high degree of transfection efficiency and at the same time a low cell mortality. Different cell types, in particular dormant and actively dividing cells of low activity, can be successfully transfected in said buffer solution.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

It is an object of the present invention to provide a biosensor, which is not significantly affected by the baseline fluctuation and suppresses nonspecific adsorption. The present invention provides a biosensor, which comprises a metal surface or metal film coated with a hydrophobic polymer, and has two or more types of different surfaces in a region coated with a hydrophobic polymer.

In a first display mode, a common image function component is displayed to occupy at least a part of a display region of a second specific image function component. In a second display mode, the common image function component is continuously displayed outside the second specific image function component to avoid the overlap therebetween (i.e., such that an exclusive positional relationship is made therebetween). When the display mode is switched, a final transition of the display mode to a display state in the second display mode is made while or after a moving image showing a transition process, in which the common image function component is moved from a display position in the first display mode to a display position in the second display mode, is displayed as a mode transition animation.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. Liquid formulations, including solutions and suspensions of the various drugs, agents and/or compounds, may be locally or regionally delivered. In each of these instances, antioxidants are utilized to prolong product integrity.

A method of reducing or eliminating change in a cash transaction includes receiving a cash payment for an article or a service from a buyer; and crediting at least part of change from the cash payment due the buyer to an account of the buyer over an electronic medium. A system of reducing or eliminating change in a cash transaction includes a merchant terminal that processes a cash payment received from a buyer for an article or a service; a communication device that sends a message over an electronic medium specifying that at least part of change from the cash payment is to be credited to an account of the buyer; and a change credit apparatus that credits the at least part of the change to the buyer's account.